BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16935809)

  • 1. Development of psoriasis after meloxicam.
    Ilknur T; Fetil E; Akarsu S; Arda F; Sis B; Günes AT
    Eur J Dermatol; 2006; 16(4):444-5. PubMed ID: 16935809
    [No Abstract]   [Full Text] [Related]  

  • 2. [Upper digestive hemorrhage caused by meloxicam].
    del Val A; Llorente MJ; Tenías JM; Lluch A
    Rev Esp Enferm Dig; 1998 Jun; 90(6):461-2. PubMed ID: 9708012
    [No Abstract]   [Full Text] [Related]  

  • 3. Meloxicam-induced liver toxicity.
    Staerkel P; Horsmans Y
    Acta Gastroenterol Belg; 1999; 62(2):255-6. PubMed ID: 10427794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meloxicam-induced pulmonary infiltrates with eosinophilia: a case report.
    Karakatsani A; Chroneou A; Koulouris NG; Orphanidou D; Jordanoglou J
    Rheumatology (Oxford); 2003 Sep; 42(9):1112-3. PubMed ID: 12923267
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastrointestinal complications and meloxicam.
    Fenn GC; Morant SV; Shield MJ
    Br J Rheumatol; 1997 Nov; 36(11):1234. PubMed ID: 9402874
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid onset of neurological symptoms and lithium toxicity on starting meloxicam.
    Chen L; Pym H
    Aust N Z J Psychiatry; 2010 Jan; 44(1):95. PubMed ID: 20073572
    [No Abstract]   [Full Text] [Related]  

  • 7. Spontaneous bruising, haematomata and prolonged APTT with meloxicam.
    Kurien AM
    Med J Aust; 2005 Aug; 183(4):219. PubMed ID: 16097928
    [No Abstract]   [Full Text] [Related]  

  • 8. Meloxicam-induced erythema multiforme.
    Nikas SN; Kittas G; Karamaounas N; Drosos AA
    Am J Med; 1999 Nov; 107(5):532-4. PubMed ID: 10569318
    [No Abstract]   [Full Text] [Related]  

  • 9. Meloxicam-induced enteropathy of the small bowel.
    Are C; Turagam M; Aucar JA; Greenberg E
    CMAJ; 2011 Mar; 183(5):577-80. PubMed ID: 20974723
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy and intolerance of meloxicam in injection and tablet form].
    Tiurin VP; Rakov AL
    Voen Med Zh; 2003 Nov; 324(11):54-8. PubMed ID: 14725079
    [No Abstract]   [Full Text] [Related]  

  • 11. [Meloxican-induced cholestasis].
    Gierer IM; Abdala O; Calderón C; Risoli E; Cravero A; Pinchuk L
    Acta Gastroenterol Latinoam; 2000; 30(5):511-4. PubMed ID: 11144948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible anaphylactoid reaction in a cow after intravenous meloxicam.
    Okushima S; Chesnel MA; Clutton RE
    Vet Anaesth Analg; 2013 May; 40(3):333-4. PubMed ID: 23438083
    [No Abstract]   [Full Text] [Related]  

  • 13. Ischaemic colitis in a patient taking meloxicam.
    Garcia B; Ramaholimihaso F; Diebold MD; Cadiot G; Thiéfin G
    Lancet; 2001 Mar; 357(9257):690. PubMed ID: 11247558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meloxicam complexation with beta-cyclodextrin: influence on the anti-inflammatory and ulcerogenic activity.
    Baboota S; Agarwal SP
    Pharmazie; 2003 Jan; 58(1):73-4. PubMed ID: 12622261
    [No Abstract]   [Full Text] [Related]  

  • 15. [Meloxicam: intramuscular administration in rheumatology].
    Tsvetkova ES
    Ter Arkh; 2003; 75(8):96-7. PubMed ID: 14520864
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of nimesulide, meloxicam and rofecoxib as alternative analgesics.
    Karakaya G; Kalyoncu AF
    Allergol Immunopathol (Madr); 2000; 28(6):319-21. PubMed ID: 11269899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meloxicam--a safer NSAID?
    Drug Ther Bull; 1998 Aug; 36(8):62-4. PubMed ID: 9876404
    [No Abstract]   [Full Text] [Related]  

  • 18. Meloxicam as a cause of drug-induced autoimmune hepatitis.
    Martínez-Odriozola P; Gutiérrez-Macías A; Ibarmia-Lahuerta J; Muñóz-Sánchez J
    Dig Dis Sci; 2010 Apr; 55(4):1191-2. PubMed ID: 19399620
    [No Abstract]   [Full Text] [Related]  

  • 19. [The new nonsteroidal anti-inflammatory preparation meloxicam in the treatment of rheumatoid arthritis].
    Grishina EI
    Lik Sprava; 1997; (2):19-25. PubMed ID: 9333474
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Layton et al. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring data.
    Degner F; Lesaffre E; Zeidler H
    Rheumatology (Oxford); 2004 May; 43(5):680-1; author reply 681-2. PubMed ID: 15103042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.